Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons
Open Access
- 23 July 2014
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 21 (9) , 1339-1342
Abstract
Hepatitis B antibody persistence was assessed in individuals who had previously received a vaccine booster. We measured hepatitis B surface antigen antibody (anti-HBs) levels 7 to 9 years post-hepatitis B booster in individuals with primary vaccination at birth. While 95 (91.3%) of 104 participants had detectable anti-HBs (minimum, 0.1 mIU/ml; maximum, 1,029 mIU/ml), only 43 (41%) had protective levels of ≥10 mIU/ml. Pre- and week 4 postbooster anti-HBs levels were significant predictors of hepatitis B immunity at follow-up (P< 0.001). Almost all participants had detectable anti-HBs 7 to 9 years after the hepatitis B vaccine booster, but less than half had levels ≥10 mIU/ml.Keywords
This publication has 14 references indexed in Scilit:
- CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.2013
- Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22‐Year Follow‐Up Study and Response to a Booster DoseThe Journal of Infectious Diseases, 2009
- Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final reportVaccine, 2008
- Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in AdolescencePLOS ONE, 2007
- Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During InfancyPediatrics, 2007
- Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccinationVaccine, 2006
- Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutantsVaccine, 2005
- Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in ItalyVaccine, 2003
- Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization ProgramThe Journal of Infectious Diseases, 2000
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000